中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基于生物信息学分析Mindin低表达Huh7细胞的差异表达基因

张欣 王沐淇 王文俊 李亚萍 石娟娟 李梅 贾晓黎 党双锁

郭严, 张世荣, 文良志, 刘凯军, 胡辂, 孙文静, 王斌, 魏艳玲, 陈东风. 我国吡咯烷生物碱致肝窦阻塞综合征的临床特征分析[J]. 临床肝胆病杂志, 2018, 34(6): 1277-1281. DOI: 10.3969/j.issn.1001-5256.2018.06.029.
引用本文: 郭严, 张世荣, 文良志, 刘凯军, 胡辂, 孙文静, 王斌, 魏艳玲, 陈东风. 我国吡咯烷生物碱致肝窦阻塞综合征的临床特征分析[J]. 临床肝胆病杂志, 2018, 34(6): 1277-1281. DOI: 10.3969/j.issn.1001-5256.2018.06.029.
Guo Yan, Zhang ShiRong, Wen LiangZhi, Liu KaiJun, Hu Lu, Sun WenJing, Wang Bin, Wei YanLing, Chen DongFeng. Clinical features of sinusoidal obstruction syndrome induced by pyrrolidine alkaloids in China[J]. J Clin Hepatol, 2018, 34(6): 1277-1281. DOI: 10.3969/j.issn.1001-5256.2018.06.029.
Citation: Guo Yan, Zhang ShiRong, Wen LiangZhi, Liu KaiJun, Hu Lu, Sun WenJing, Wang Bin, Wei YanLing, Chen DongFeng. Clinical features of sinusoidal obstruction syndrome induced by pyrrolidine alkaloids in China[J]. J Clin Hepatol, 2018, 34(6): 1277-1281. DOI: 10.3969/j.issn.1001-5256.2018.06.029.

基于生物信息学分析Mindin低表达Huh7细胞的差异表达基因

DOI: 10.3969/j.issn.1001-5256.2019.10.028
基金项目: 

国家自然科学基金(81500453); 陕西省社发科技攻关项目(S2015YFSF0363); 

详细信息
  • 中图分类号: Q811.4;R341

A bioinformatics analysis of differentially expressed genes in Huh7 cells with low expression of Mindin

Research funding: 

 

  • 摘要:

    目的构建Mindin低表达的Huh7细胞并对其进行转录组学研究,以探索Mindin的生物学作用。方法设计并合成Mindin干扰序列,通过慢病毒载体GV248将其导入Huh7细胞,实时定量PCR检测对Mindin转录水平的抑制效果,获得Mindin低表达Huh7细胞并对该细胞及其对照细胞进行转录组学研究,生物信息学分析表达异常基因,Pathway分析Mindin可能参与的生物学功能。计量资料2组间比较采用t检验。结果与对照细胞相比,含干扰序列的慢病毒感染Huh7细胞后,其Mindin mRNA的敲减效率为63. 8%(P=0. 003)。Mindin稳定低表达的Huh7细胞迁移率明显高于对照细胞(3. 511±0. 538 vs 1. 701±0. 765,t=-3. 355,P=0. 03)。与对照细胞相比,Mindin低表达Huh7细胞有2888个上调基因,2516个下调基因。取满足∣log2FC∣> 2. 0且P<0. 05的895个差异表达基因进行GO分析和Pathway分析。Pathway分析排名前10位的Mindin参与的生物学功能依次为:肿瘤信号通路、趋化因子...

     

  • [1] FEINSTEIN Y,BORRELL V,GARCIA C,et al. F-spondin and mindin:Two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons[J]. Development, 1999, 126(16):3637-3648.
    [2] JIA W,LI H,HE YW. The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment[J]. Blood,2005,106(12):3854-3859.
    [3] LIU YS,WANG LF,CHENG XS,et al. The pattern-recognition molecule mindin binds integrin Mac-1 to promote macrophage phagocytosis via Syk activation and NF-kappab p65translocation[J]. J Cell Mol Med,2019,23(5):3402-3416.
    [4] WANG LF,LIU YS,YANG B,et al. The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation[J]. Oncogene,2018,37(5):601-615.
    [5] GULENG B,LIAN YM,REN JL. Mindin is upregulated during colitis and may activate NF-kappaB in a TLR-9 mediated manner[J]. World J Gastroenterol,2010,16(9):1070-1075.
    [6] NAUDIN C,SMITH B,BOND DR,et al. Characterization of the early molecular changes in the glomeruli of Cd151(-/-)mice highlights induction of mindin and MMP-10[J]. Sci Rep,2017,7(1):15987.
    [7] DOGˇAN T,YETIM M,ELIK O,et al. Investigation of mindin levels in hypertensive patients with left ventricular hypertrophy and QRS fragmentation on electrocardiography[J]. Acta Cardiol,2018,73(6):544-549.
    [8] MACRITCHIE N,MAFFIA P.'Blow my mind(in)'-mindin neutralization for the prevention of atherosclerosis?[J]. Clin Sci(Lond),2018,132(14):1509-1512.
    [9] WANG L,LU Y,ZHANG X,et al. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model[J].Exp Neurol,2013,247:506-516.
    [10] JIA W,LI H,HE YW. Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses[J]. J Immunol,2008,180(9):6255-6261.
    [11] HE YW,LI H,ZHANG J,et al. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens[J]. Nat Immunol,2004,5(1):88-97.
    [12] LI H,OLIVER T,JIA W,et al. Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin[J]. EMBO J,2006,25(17):4097-4107.
    [13] LIAO CH,YEH SC,HUANG YH,et al. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion[J]. Endocr Relat Cancer,2010,17(1):99-111.
    [14] LUO JH,REN B,KERYANOV S,et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas[J]. Hepatology,2006,44(4):1012-1024.
    [15] ZHANG YL,LI Q,YANG XM,et al. SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin-Rho GTPase-hippo pathways[J]. Cancer Res,2018,78(9):2305-2317.
    [16] RAJKUMAR T,VIJAYALAKSHMI N,GOPAL G,et al. Identification and validation of genes involved in gastric tumorigenesis[J]. Cancer Cell Int,2010,10:45.
    [17] JIN C,LIN JR,MA L,et al. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer[J]. Oncotarget,2017,8(6):10416-10424.
    [18] CHANDRASINGHE P,STEBBING J,WARUSAVITARNE J. The MACC1-SPON2 axis:A new biomarker and therapeutic target in colorectal cancer[J]. Oncogene,2017,36(11):1474-1475.
    [19] SCHMID F,WANG Q,HUSKA MR,et al. Spon2,a newly identified target gene of macc1,drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival[J]. Oncogene,2016,35(46):5942-5952.
    [20] ZHANG Q,WANG XQ,WANG J,et al. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients[J].Oncotarget,2015,6(17):15095-15110.
    [21] SIMON I,LIU Y,KRALL KL,et al. Evaluation of the novel serum markers B7-H4,spondin 2,and DcR3 for diagnosis and early detection of ovarian cancer[J]. Gynecol Oncol,2007,106(1):112-118.
    [22] QIAN X,LI C,PANG B,et al. Spondin-2(SPON2),a more prostate-cancer-specific diagnostic biomarker[J]. PLo S One,2012,7(5):e37225.
    [23] LUCARELLI G,RUTIGLIANO M,BETTOCCHI C,et al. Spondin-2,a secreted extracellular matrix protein,is a novel diagnostic biomarker for prostate cancer[J]. J Urol,2013,190(6):2271-2277.
    [24] YUAN X,BIAN T,LIU J,et al. Spondin2 is a new prognostic biomarker for lung adenocarcinoma[J]. Oncotarget,2017,8(35):59324-59332.
    [25] HERS I,VINCENT EE,TAVARJM. Akt signalling in health and disease[J]. Cell Signal,2011,23(10):1515-1527.
    [26] SUN P,ZHANG P,WANG PX,et al. Mindin deficiency protects the liver against ischemia/reperfusion injury[J]. J Hepatol,2015,63(5):1198-1211.
    [27] ZHANG X,WANG W,ZHAI S,et al. Down-regulated expression of pattern recognition molecule mindinmindin in acute hepatic injury induced by CCl4in mice[J]. J Clin Hepatol,2019,35(2):368-371.(in Chinese)张欣,王文俊,翟嵩,等.模式识别分子Mindin蛋白在CCl4诱导急性肝损伤小鼠模型中的表达[J].临床肝胆病杂志,2019,35(2):368-371.
    [28] ZHU LH,WANG A,LUO P,et al. Mindin/spondin 2 inhibits hepatic steatosis,insulin resistance,and obesity via interaction with peroxisome proliferator-activated receptor alpha in mice[J]. J Hepatol,2014,60(5):1046-1054.
    [29] FENG Y,HU Y,MAO Q,et al. Upregulation of spondin-2protein expression correlates with poor prognosis in hepatocellular carcinoma[J]. J Int Med Res,2019,47(2):569-579.
    [30] HAO PQ,ZHANG XY,GUO H,et al. Research progress on pathophysiological function of SOS1 protein[J]. Acta Physiologica Sinica,2018,70(5):107-112.(in Chinese)郝佩琪,张新宇,郭慧,等. SOS1蛋白病理生理功能研究进展[J].生理学报,2018,70(5):107-112.
    [31] YU Y,WU TT,JIANG CL,et al. Effects of hepatitis B virus X protein on cell proliferation and GSK3βexpression of human liver cell line L02[J]. Cancer,2011,31(5):406-411.(in Chinese)喻垚,吴婷婷,蒋崇亮,等.乙型肝炎病毒X蛋白对肝细胞L02增殖及GSK3β表达的影响[J].肿瘤,2011,31(5):406-411.
  • 期刊类型引用(25)

    1. 胡馨月,文良志,王斌,魏艳玲,崔红利,陈东风. 2410例肝窦阻塞综合征患者临床特征的系统分析. 胃肠病学和肝病学杂志. 2024(01): 9-14 . 百度学术
    2. 张万钦,朱芳. 狗舌草致肝窦阻塞综合征. 药物不良反应杂志. 2024(01): 56-58 . 百度学术
    3. 刘盼盼,陶运生. 乙肝肝硬化合并肝窦阻塞综合征1例. 现代医药卫生. 2024(16): 2877-2880 . 百度学术
    4. 白婷婷,刘钰懿,陈东风. 肝脏血管性疾病诊断与鉴别诊断. 实用肝脏病杂志. 2023(02): 153-155 . 百度学术
    5. 李立,罗轶,李丽莉,蒋湘,黄燕红. 白背三七中吡咯里西啶生物碱的含量分析及风险评价. 西北药学杂志. 2023(05): 31-36 . 百度学术
    6. 贾翠宇,赵大伟,冯骥良,宋文艳,王欣欣. 肝窦阻塞综合征的临床和影像学表现. 临床放射学杂志. 2022(02): 284-288 . 百度学术
    7. 石玉芝,陈芳,许剑. 土三七致大鼠肝窦阻塞综合征发病机制研究. 现代医学与健康研究电子杂志. 2022(06): 99-103 . 百度学术
    8. 李宗明,韩新巍,丁鹏绪,周朋利,焦德超,雷钦宇,徐苗. 经颈静脉肝内门体分流术治疗慢性期肝小静脉闭塞症疗效观察. 郑州大学学报(医学版). 2022(03): 422-426 . 百度学术
    9. 尚亚男,徐浩,郭潇,王仲恺. 土三七致肝窦阻塞综合征的临床及CT特征研究. 医学影像学杂志. 2022(08): 1317-1322 . 百度学术
    10. 昝珂,周颖,李耀磊,王莹,金红宇,左甜甜,马双成. 赤小豆中吡咯里西啶生物碱氮氧化物含量测定及安全风险评估. 中国药物警戒. 2022(11): 1186-1190 . 百度学术
    11. 昝珂,蒋黄卉,金红宇,马双成,赵磊,孙艳涛. 中药肝毒性吡咯里西啶生物碱的质量控制研究进展. 药物分析杂志. 2021(04): 572-578 . 百度学术
    12. 昝珂,周颖,李耀磊,左甜甜,金红宇,王莹,马双成. 罗布麻叶中肝毒性成分吡咯里西啶生物碱的含量分析及其初步风险评估. 中国药事. 2021(07): 757-762 . 百度学术
    13. 昝珂,周颖,李耀磊,王莹,刘丽娜,金红宇,左甜甜,马双成. UPLC-MS/MS测定一点红不同部位中6种吡咯里西啶生物碱的含量. 中国中药杂志. 2021(17): 4456-4461 . 百度学术
    14. 昝珂,陈翠玲,周颖,左甜甜,金红宇,王莹,马双成. 马鞭草中6个肝毒性吡咯里西啶生物碱的含量测定及风险评估. 中国实验方剂学杂志. 2021(24): 157-162 . 百度学术
    15. 李惠贞,蔡剑鸣,董景辉,刘渊,任洪伟,安维民. 肝窦阻塞综合征患者临床及影像学表现分析. 中华消化病与影像杂志(电子版). 2021(06): 263-267 . 百度学术
    16. 昝珂,李耀磊,周颖,左甜甜,金红宇,王莹,马双成. UPLC-MS/MS法测定大蓟中7个吡咯里西啶生物碱的含量及初步风险评估. 药物分析杂志. 2021(10): 1690-1696 . 百度学术
    17. 昝珂,周颖,李耀磊,王莹,金红宇,左甜甜,刘丽娜,马双成. 半枝莲中肝毒性成分吡咯里西啶生物碱含量分析及初步风险评估. 药物评价研究. 2021(12): 2608-2613 . 百度学术
    18. 昝珂,陈翠玲,周颖,金红宇,马双成,王莹. 超高效液相色谱串联质谱法测定木贼中4种吡咯里西啶生物碱. 化学分析计量. 2021(12): 38-42 . 百度学术
    19. 昝珂,周颖,李耀磊,左甜甜,金红宇,王莹,马双成. 灯盏细辛中吡咯里西啶生物碱的含量分析及其肝毒性风险评估. 中国现代中药. 2021(11): 1897-1901 . 百度学术
    20. 戚汝平,董景辉,李勇武,安维民,任洪伟,刘渊. 26例肝窦阻塞综合征临床及影像分析. 肝脏. 2020(02): 162-165 . 百度学术
    21. 徐楠,李江,谢琴秀. 43例吡咯生物碱相关肝窦阻塞综合征临床特征及预后分析. 安徽医学. 2020(07): 797-800 . 百度学术
    22. 刘少松,周晓东. 吡咯烷生物碱诱导肝窦阻塞综合征的研究进展. 临床内科杂志. 2020(04): 256-259 . 百度学术
    23. 刘贞利,范作鹏,勾钰淞,柳雅立,张晶. 不同类型肝窦阻塞综合征的临床特征、发病机制与诊治. 临床肝胆病杂志. 2019(01): 208-212 . 本站查看
    24. 尹昕茹,陈东风. 隐源性肝硬化诊治的临床思维. 医学研究生学报. 2019(06): 576-579 . 百度学术
    25. 亓传旺,咸建春,肖丽,李阳. 土三七致肝窦阻塞综合征5例临床分析. 中国中西医结合消化杂志. 2019(07): 548-551 . 百度学术

    其他类型引用(6)

  • 加载中
计量
  • 文章访问数:  1195
  • HTML全文浏览量:  21
  • PDF下载量:  239
  • 被引次数: 31
出版历程
  • 收稿日期:  2019-06-24
  • 出版日期:  2019-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回